Navigation Links
Reactivated gene shrinks tumors

Many cancers arise due to defects in genes that normally suppress tumor growth. Now, for the first time, MIT researchers have shown that re-activating one of those genes in mice can cause tumors to shrink or disappear.

The study offers evidence that the tumor suppressor gene p53 is a promising target for human cancer drugs.

"If we can find drugs that restore p53 function in human tumors in which this pathway is blocked, they may be effective cancer treatments," said David Kirsch of MIT's Center for Cancer Research and Harvard Medical School, one of the lead co-authors of the paper.

The study will be published in the Jan. 24 online edition of Nature. It was conducted in the laboratory of Tyler Jacks, director of the Center for Cancer Research, the David H. Koch Professor of Biology and a Howard Hughes Medical Institute investigator.

P53 has long been known to play a critical role in the development of many tumors-it is mutated in more than 50 percent of human cancers. Researchers have identified a few compounds that restore p53 function, but until now, it has not been known whether such activity would actually reverse tumor growth in primary tumors.

The new MIT study shows that re-activating p53 in mouse tumors dramatically reduces the size of the tumors, in some cases by 100 percent.

"This study provides critical genetic evidence that continuous repression of a tumor suppressor gene is required for a tumor to survive," said Andrea Ventura, an Italian postdoctoral associate in the Center for Cancer Research and first author of the paper.

In normal cells, p53 controls the cell cycle. In other words, when functioning properly, it activates DNA repair mechanisms and prevents cells with damaged DNA from dividing. If DNA damage is irreparable, p53 induces the cell to destroy itself by undergoing apoptosis, or programmed cell death.

When p53 is turned off by mutation or deletion, cells are much
'"/>

Source:Massachusetts Institute of Technology


Page: 1 2 3

Related biology news :

1. Ultrasounds show mothers drinking shrinks fetal brain
2. Overfishing large sharks impacts entire marine ecosystem, shrinks shellfish supply
3. Pulsating ultrasound enhances gene therapy for tumors
4. A new link between stem cells and tumors
5. Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors
6. Double trouble: Cells with duplicate genomes can trigger tumors
7. Common molecular signature identified in solid tumors
8. Virus chip detects new virus in prostate tumors
9. Macrophage signaling may affect hormone resistance in prostate tumors
10. Common molecular signature identified in solid tumors
11. Vegetables inhibit growth of prostate cancer in mice with human tumors
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reactivated gene shrinks tumors

(Date:12/11/2009)... edition of Springer,s classic reference and textbook Vogel and ... McKusick Leadership Award. The prize, which recognizes Professor Motulsky,s ... presented to him at the 59th Annual Meeting of ... 2009 in Honolulu, Hawaii. , Motulsky is Professor Emeritus ... Washington in Seattle. One of the founding giants of ...
(Date:12/11/2009)... smoking is a health risk but why do teens ... an evaluation for Faculty of 1000 Biology, Neil Grunberg ... abuse. , Grunberg describes the study, published by Natividad ... and suggests it "may have implications to help understand ... Nicotine increases the level of dopamine in the brain, ...
(Date:12/11/2009)... 190 nations are gathered at the two-week UN ... 150 distinguished guests attended an ESA-hosted side event ... Climate Variables,. , During the event, speakers from ... satellites play in providing systematic global climate observations. ... and for managing mitigation and adaptation strategies. ,The ...
Breaking Biology News(10 mins):Space agencies join forces to systematically observe climate variables 2Space agencies join forces to systematically observe climate variables 3Chemotherapy for breast cancer is associated with disruption of sleep wake rhythm in women 55788 1Chemotherapy for breast cancer is associated with disruption of sleep wake rhythm in women 55788 2Chemotherapy for breast cancer is associated with disruption of sleep wake rhythm in women 55788 3Hidden diversity in key environmental cleanup microbes found by systems biology assessment 13744 1Hidden diversity in key environmental cleanup microbes found by systems biology assessment 13744 2Hidden diversity in key environmental cleanup microbes found by systems biology assessment 13744 3ECI Hires Robin Raff as Director of Strategy 55780 1ECI Hires Robin Raff as Director of Strategy 55780 2
... years, there has been growing interest in the question, ... soils via manure application is of environmental relevance. In ... the journal CLEAN, Kreuzig and co-workers now focused on ... data to the so far available data set on ...
... Scientists from the John Innes Centre have proven that ... bacterium and delivering it with an existing antibiotic they ... technology transfer company PBL, the scientists have launched a ... , The DNA sequence acts as a decoy, disrupting ...
... begun in the protected spaces inside of layers of the ... , The hypothesis was developed by Helen Hansma, a research ... program director at the National Science Foundation. Hansma will present ... at the annual meeting of the American Society for Cell ...
Other Biology News:New insights into the fate of antiparasitics in manure and manured soils 2Decoy makes sitting duck of superbugs 2New hypothesis for origin of life proposed 2
(Date:12/11/2009)... December 2009 -- Researchers have discovered a new explanation for ... more excess copies of a certain gene, the more serious ... and it is suspected that it is the amount of ... are being published in the American Journal of Human ... group of Guy Froyen connected to VIB, a life sciences ...
(Date:12/11/2009)... Dec. 11 Gwathmey, Inc., a pre-clinical ... cancer, staph aureus, and cardiovascular disease announces a ... today that Rosalie Dunn, Ph.D., has joined Gwathmey ... over 28 years of experience working with small ... joining Gwathmey, Dr. Dunn managed multimillion dollar portfolios ...
(Date:12/10/2009)... Endologix, Inc. (Nasdaq: ELGX ), ... announced today that Dan Lemaitre, former President and ... of Directors effective December 11, 2009. Endologix ... directors. ,, Franklin D. Brown, Chairman of the ... Lemaitre to the Endologix Board of Directors. ...
(Date:12/10/2009)... advanced flow measurement, control, and level solutions, announced ... Global Level Product Manager effective November 30, 2009. ... market penetration of the level measurement products around ... Lafarge Corp, a manufacturer of building materials, where ... Bayda will report to Brooks Instrument Vice President ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Endologix Appoints Dan Lemaitre to its Board of Directors 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
... Treatment from Abbott Shows No Thrombosis, Low MACE Rates ... Clinical Study of Thirty Patients, ABBOTT PARK, Ill., ... ABSORB, the world,s first clinical trial of a,fully bioabsorbable ... demonstrated no stent thrombosis, no clinically driven target,lesion revascularizations ...
... Therapeutics,Inc. (OTC Bulletin Board: NILT), today announced its ... Participants may access the archived,webcast of the conference ... at http://www.nilethera.com . The webcast will remain ... conference call., For the fourth quarter of ...
... March 13 Unigene,Laboratories, Inc. (OTCBB: UGNE) ... approve the press release titled "Stonegate Report ... Pursuant to the Company,s,policies and procedures, Unigene ... on reports issued by analysts and unrelated ...
Other Biology Technology:The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 4Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 2Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3Unigene Restates Policy on Analyst Reports 2
... BalanceTalk XL provides balance data collection and ... Complete integration with Microsoft Excel , ... moisture analyzers , New balances can be added ... Collect data from multiple balances into one spreadsheet ...
...
Peptide-affinity Purified Polyclonal Antibody to MAML1 / Mastermind Peptide with sequence VLPTCPMAEFALPR, from N Terminus of the protein sequence according to NP_055572....
One unit is equal to 10Kb (insert DNA + vector). The final cost will increase or decrease according to the final assembled genome size. The price does not include genome annotation....
Biology Products: